Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

3 1

What is this study about?

This clinical trial is focused on studying acute myocardial infarction, commonly known as a heart attack. The study is evaluating a treatment called Selatogrel, which is a solution for injection that participants can administer themselves using a pre-filled injector. The purpose of the study is to assess how effective and safe Selatogrel is when used to prevent death from any cause and to treat heart attacks in people who have recently experienced one.

Participants in the study will be randomly assigned to receive either Selatogrel or a Selatogrel matching placebo. The study is designed to be double-blind, meaning neither the participants nor the researchers will know who is receiving the actual treatment or the placebo. This helps ensure that the results are unbiased. The study will follow participants over a period to observe the occurrence of death or another heart attack after they have self-administered the treatment.

The study will also monitor for any safety concerns, such as bleeding events, that may occur within two days after taking the treatment. Additionally, researchers will look at other outcomes like hospital visits for heart failure within 30 days after treatment. This trial aims to provide valuable information on the potential benefits and risks of using Selatogrel for individuals at risk of having another heart attack.

1 joining the study

Upon joining the study, the participant must have signed and dated the informed consent form. This confirms understanding and agreement to participate in the study.

The participant must be at least 18 years old and have a confirmed diagnosis of a recent acute myocardial infarction (AMI), either STEMI or NSTEMI, within the last four weeks.

2 eligibility confirmation

Eligibility is confirmed by the presence of multivessel coronary artery disease, defined as 50% or more stenosis in two or more coronary artery territories or the left main artery.

Additional risk factors such as a second prior AMI, diabetes, chronic kidney disease, peripheral artery disease, or unsuccessful coronary revascularization are considered.

3 self-administration training

Participants must successfully self-administer a placebo using an autoinjector during the screening phase. This ensures familiarity with the device and procedure.

4 treatment phase

During the treatment phase, participants will self-administer selatogrel or a matching placebo subcutaneously. This is done upon experiencing symptoms suggestive of an AMI.

The medication is provided in a solution for injection in a pre-filled injector.

5 monitoring and follow-up

Participants are monitored for the occurrence of death or non-fatal AMI after any self-administration of the study treatment. The severity of outcomes is ranked, with death being the most severe.

Safety is assessed by monitoring for treatment-emergent bleeding events within two days after administration.

6 secondary outcomes

Secondary outcomes include the occurrence of death, non-fatal AMI, hospitalization, or unplanned emergency department visits for heart failure within 30 days after any treatment administration.

Who Can Join the Study?

  • Sign and date an informed consent form before any study-related procedures. This means you agree to participate and understand what the study involves.
  • Be a male or female who is at least 18 years old when signing the consent form.
  • Have a confirmed diagnosis of a Type 1 acute myocardial infarction. This is a type of heart attack. It should be either a ST-elevation myocardial infarction (STEMI) or a Non-ST-elevation myocardial infarction (NSTEMI), and it must have occurred no more than 4 weeks before joining the study.
  • Have multivessel coronary artery disease. This means there is a narrowing of 50% or more in two or more areas of the heart’s blood vessels, or in the main artery of the heart. This should have been found during a heart test called cardiac catheterization. You also need to have at least two of the following risk factors:
    • Had a second heart attack before.
    • Have diabetes mellitus, which is a condition where your body has trouble controlling blood sugar, and you are receiving treatment for it.
    • Have chronic kidney disease, meaning your kidneys are not working well, with a specific measure called estimated glomerular filtration rate being less than 60.
    • Have peripheral artery disease, which is a condition affecting blood flow in the limbs, at any time before joining the study.
    • Have not had, or had unsuccessful, heart vessel repair for the heart attack that qualifies you for the study.
  • Successfully use a placebo, which is a harmless substance, with an autoinjector device during the screening process. This shows you can use the device correctly.

Who Cannot Join the Study?

  • Individuals who have had a recent acute myocardial infarction (AMI), which is a heart attack.
  • People who are not able to self-administer the study medication when they experience symptoms that might suggest a heart attack.
  • Participants who are not at risk of having another heart attack.
  • Individuals who are not within the specified age range for the study.
  • People who are not part of the specified clinical trial groups.
  • Participants who are not male or female, as the study includes both genders.
  • Individuals who are considered part of a vulnerable population, which means they might need special protection or care.

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

Site Name City Country Status
Kat Attica General Hospital Kifissia Greece
Hospital Jihlava Jihlava Czechia
Sydvestjysk Sygehus Esbjerg Denmark
Azienda Ospedaliera Universitaria Federico II Di Napoli Naples Italy
Medical University Of Graz Graz Austria
Hospital Universitario De Navarra Pamplona Spain
NZOZ „Pro Cordis” Sopockie Centrum Badań Kardiologicznych Paweł Miękus Sopot Poland
INKARD Sp. Z O.O. Sp. JAWNA Poznan Poland
Region Vaestmanland Vasteras Sweden
CorMedico s.r.o. Bruntal Czechia
Zuyderland Medisch Centrum Stichting Geleen The Netherlands
CINRE s.r.o. Petrzalka Slovakia
Medical Center St. Ivan Rilski Chudotvorets 2010 EOOD Plovdiv Bulgaria
Multiprofile Hospital For Active Treatment Ivan Skenderov EOOD Gotse Delchev Bulgaria
Klinički bolnički centar Zagreb (University Hospital Center Zagreb) Zagreb Croatia
4 Wojskowy SzpitaKliniczny Z Polikliniką Samodzielny Publiczny ZakładOpieki ZdrowotneWe Wrocławiu Wroclaw Poland
Hospital Clinico San Carlos Madrid Spain
Spitalul Clinic Judetean De Urgenta Cluj Cluj Napoca Romania
Centre Hospitalier Regional Et Universitaire De Brest Brest France
Azienda Ospedaliero Universitaria Careggi Florence Italy
Technische Universitaet Dresden Dresden Germany
Katholieke Universiteit te Leuven Leuven Belgium
Oslo Universitetssykehus HF Oslo Norway
Augustinerinnen Krankenhaeuser gGmbH Cologne Germany
Jorvi Hospital Espoo Finland
Kuopio University Hospital Kuopio Finland
Bellvitge University Hospital L'hospitalet De Llobregat Spain
Stichting OLVG Amsterdam The Netherlands
Nemocnice Pardubickeho kraje a.s. Pardubice Czechia
Etela-Pohjanmaan Sairaanhoitopiiri Seinajoki Finland
Centrum Medyczne “Hipokrates” s.c. Elżbieta i Grzegorz Grześk Bydgoszcz Poland
Uniwersytecki Szpital Kliniczny Im Jana Mikulicza Radeckiego We Wroclawiu Wroclaw Poland
Gyncentrum Sp. z o.o. Katowice Poland
Unidade Local De Saúde De Santa Maria, E.P.E. Lisbon Portugal
NZOZ Neuro-Kard Ilkowski i Partnerzy Spółka Partnerska Lekarzy Poznan Poland

Other Sites

Site Name City Country Status
Pauls Stradins Clinical University Hospital Riga Latvia
University Multiprofile Hospital For Active Treatment Sofiamed OOD Sofia Bulgaria
Hippokration Hospital Athens Greece
Slaskie Centrum Chorob Serca W Zabrzu Zabrze Poland
Fakultni Nemocnice Plzen Plzen Czechia
Landeskrankenanstalten-Betriebsgesellschaft Kabeg Klagenfurt am Wörthersee Austria
Diagnostic & Therapeutic Center Of Athens Hygeia Single Member S.A. Athens Greece
MHAT National Heart Hospital EAD Sofia Bulgaria
Universitaetsklinikum Regensburg AöR Regensburg Germany
Azienda Ospedaliero-Universitaria San Luigi Gonzaga Orbassano Italy
Fondazione IRCCS Policlinico San Matteo Pavia Italy
Vilniaus universiteto ligonine Santaros klinikos VšĮ Vilnius Lithuania
Catharina Ziekenhuis Stichting Eindhoven The Netherlands
Fakultni Nemocnice Brno Brno Czechia
Fakultni Nemocnice Hradec Kralove Novy Hradec Kralove Czechia
Universitaetsklinikum Mannheim GmbH Mannheim Germany
Fakultni Nemocnice Kralovske Vinohrady Prague Czechia
University Clinical Hospital Virgen De La Arrixaca Murcia Spain
Universitair Medisch Centrum Groningen Groningen The Netherlands
Fakultni Nemocnice U Sv Anny V Brne Brno-Stred Czechia
General University Hospital Of Patras Patras Greece
Belvarosi Egeszseghaz Kft. Zalaegerszeg Hungary
Medical Center – University Of Freiburg Bad Krozingen Germany
Deventer Ziekenhuis Deventer The Netherlands
Medisch Centrum Leeuwarden B.V. Leeuwarden The Netherlands
Muenchen Klinik gGmbH Munich Germany
University General Hospital Of Alexandroupoli Alexandroupoli Greece
Centro Hospitalar Do Baixo Vouga E.P.E. (CHBV E.P.E.) Aveiro Portugal
Bravis Ziekenhuis Roosendaal The Netherlands
Spital Judetean De Urgenta Satu Mare Satu Mare Romania
Ziekenhuis Oost Limburg Genk Belgium
Danderyds Sjukhus AB Danderyd Sweden
Region Oestergoetland Linkoping Sweden
Region Oerebro Laen Orebro Sweden
Vivantes Netzwerk fuer Gesundheit GmbH Berlin Germany
Azienda Sanitaria Universitaria Friuli Centrale Udine Italy
Hospital General Universitario Gregorio Maranon Madrid Spain
Amphia Hospital Breda The Netherlands
Helse Stavanger HF Stavanger Norway
Tergooiziekenhuizen Hilversum The Netherlands
Spitalul Clinic Judetean De Urgenta Craiova Craiova Romania
Delta Health Care S.R.L. Bucharest Romania
Centrul Medical Unirea S.R.L. Brasov Romania
Bekes Varmegyei Koezponti Korhaz Gyula Hungary
Region Skane Helsingborg Hospital Helsingborg Sweden
Medicali’s S.R.L. Timisoara Romania
Daugavpils regionala slimnica SIA Daugavpils Latvia
Policlinica Gipuzkoa S.A. Donostia / San Sebastian Spain
Hospital Universitario Torrecardenas Almeria Spain
Ippokratio General Hospital Of Thessaloniki Thessaloniki Greece
Umbal – Prof. D-R Stoyan Kirkovich AD Stara Zagora Bulgaria
Centrum Medyczne Med-Gastr Sp. z o.o. Lodz Poland
Region Dalarna Falun Sweden
Clinical Medical Research Sp. z o.o. Katowice Poland
Nordlandssykehuset HF Bodo Norway
Spitalul Judetean De Urgenta Braila Braila Romania
Specijalna Bolnica Za Medicinsku Rehabilitaciju Krapinske Toplice Krapinske Toplice Croatia
Multiprofile Hospital For Active Treatment-Uni Hospital Ltd. Panagyurishte Bulgaria
Multi-profile Hospital for Active Treatment Heart and Brain EAD Pleven Bulgaria
Linden Sp. z o.o. sp.k. Cracow Poland
Opca Bolnica Dubrovnik Dubrovnik Croatia
Sykehuset Oestfold HF Kalnes Graalum Norway
Vrinnevisjukhuset I Norrkoeping Region Oestergoetland Norrkoping Sweden
Azienda Unita Sanitaria Locale Di Bologna Bologna Italy
Azienda Ospedaliera Sant Anna E San Sebastiano Di Caserta Caserta Italy
Uniwersytecki Szpital Kliniczny W Poznaniu Poznan Poland
MBAL Sveta Karidad EAD Plovdiv Bulgaria
South West Hospital Ltd. Sandanski Bulgaria
Emergency Institute For Cardiovascular Diseases And Transplant Targu Mures Romania
Hospital Quironsalud Malaga Malaga Spain
Sørlandet sykehus Kristiansand Kristiansand Norway
Region Skane Skanes Universitetssjukhus Lund Sweden
Ziekenhuis Gelderse Vallei Stichting Ede The Netherlands
University Multiprofile Hospital For Active Treatment Saint Georgi EAD Plovdiv Bulgaria
University Multiprofile Hospital For Active Treatment And Emergency Medicine N I Pirogov Sofia Bulgaria
KBC Zagreb Zagreb Croatia
Evangelismos S.A. Athens Greece
Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania Catania Italy
Noe LGA Gesundheit Region Mitte GmbH St. Poelten Austria
Etg Neuroscience Sp. z o.o. Warsaw Poland
University Of Debrecen Debrecen Hungary
Spitalul Clinic Judetean De Urgenta Bihor Oradea Romania
University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD Sofia Bulgaria
University General Hospital Of Thessaloniki Ahepa Thessaloniki Greece
General Hospital Dr. Josip Bencevic Slavonski Brod Croatia
Multiprofile Regional Hospital For Active Treatment Dr. Stefan Cherkezov AD Veliko Tirnovo Bulgaria
Uniwersytecki Szpital Kliniczny W Bialymstoku Bialystok Poland
Multiprofile Hospital For Active Treatment St. Panteleimon Yambol AD Yambol Bulgaria
Gornoslaskie Centrum Mwdyczne Katowice Poland
Regionshospitalet Viborg Viborg Denmark
Diagnostic-consultative center “Aleksandrovska” EOOD Sofia Bulgaria
Bajcsy-Zsilinszky Korhaz Es Rendelointezet Budapest Hungary
Virgen del Rocío University Hospital Sevilla Spain
Odense University Hospital Odense Denmark
Les Hopitaux Universitaires De Strasbourg STRASBOURG, Alsace France
Assistance Publique Hopitaux De Paris Paris France
Universitaetsklinikum Tuebingen AöR Tuebingen Germany
Centre Hospitalier Universitaire De Toulouse Toulouse France
Universitaetsklinikum Magdeburg AöR Magdeburg Germany
Turku University Hospital Turku Finland
Centre Hospitalier Universitaire De Montpellier Montpellier France
Universidade De Santiago De Compostela Santiago De Compostela Spain
Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz Nyiregyhaza Hungary
Helios Universitaetsklinikum Wuppertal Wuppertal Germany
Aalborg University Hospital Aalborg Denmark
Multiprofile Hospital For Active Treatment Dr. Tota Venkova AD Gabrovo Bulgaria
Rheinische Friedrich-Wilhelms-Universitaet Bonn Bonn Germany
Hospital Universitari De Girona Doctor Josep Trueta Girona Spain
University Multiprophy Hospital For Active Treatment – Plovdiv AD Plovdiv Bulgaria
Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila Bucharest Romania
Region Joenkoepings Laen Jönköping Sweden
Region Midtjylland Aarhus Denmark
Geniko Nosokomeio Peiraia Tzaneio Piraeus Greece
Vseobecna Fakultni Nemocnice V Praze Prague Czechia
Rigshospitalet Copenhagen Denmark
Wojewodzki Szpital Specjalistyczny W Legnicy Legnica Poland
Azienda USL Toscana Sud Est Arezzo Italy
University Of Pecs Pecs Hungary
Gelre Hospitals Zutphen The Netherlands
Klaipedos universiteto ligonine VšĮ Klaipeda Lithuania
Pirkanmaan hyvinvointialue Tampere Finland
Spitalul Clinic Judetean Mures Targu Mures Romania
A.O.U. Policlinico G. Martino Di Messina Messina Italy
Noordwest Ziekenhuisgroep Stichting Alkmaar The Netherlands
Centre Hospitalier Universitaire De Nimes Nimes France
Azienda Provinciale Per I Servizi Sanitari Trento Italy
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer Barcelona Spain
Azienda Sanitaria Locale 5 Spezzino La Spezia Italy
Herz Und Diabeteszentrum NRW Bad Oeynhausen Universitaetsklinik Der Ruhr-Universitaet Bochum Bad Oeynhausen Germany
Robert Bosch Krankenhaus GmbH Stuttgart Germany
Barmherzige Brueder Trier gGmbH Trier Germany
Klinikum der Stadt Ludwigshafen am Rhein gGmbH Ludwigshafen Am Rhein Germany
Hospital Universitario 12 De Octubre Madrid Spain
Hospital Santa Maria Della Misericordia Perugia Italy
Jeroen Bosch Ziekenhuis Stichting s-Hertogenbosch The Netherlands
Elias University Emergency Hospital Bucharest Romania
Canisius Wilhelmina Ziekenhuis Nijmegen The Netherlands
Asklepieion Voulas General Hospital Voula Greece
Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy Warsaw Poland
Universita’ Degli Studi Di Ferrara Ferrara Italy
Algemeen Ziekenhuis Delta Roeselare Belgium
Queen Silvia Childrens Hospital – Sahlgrenska University Hospital – Vaestra Goetalandsregionen Gothenburg Sweden
Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos Kaunas Lithuania
Geniko Nosokomeio Thessalonikis George Papanikolaou Thessaloniki Greece
Herzzentrum Leipzig GmbH Leipzig Germany
Krankenhaus Nord Klinik Floridsdorf Vienna Austria
AZ Sint-Lucas & Volkskliniek Gent Belgium
Kardiocentrum Nitra s.r.o. Nitra Slovakia
Jasz-Nagykun-Szolnok Varmegyei Hetenyi Geza Korhaz-Rendelointezet Szolnok Hungary
Stadt Wien Wiener Gesundheitsverbund Vienna Austria
University General Hospital Of Heraklion Heraklion Greece
Albert Schweitzer Ziekenhuis Dordrecht The Netherlands
Ziekenhuis Rivierenland Tiel The Netherlands
Institutul De Boli Cardiovasculare Timisoara Timisoara Romania
Oulu University Hospital Oulu Finland
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego Warsaw Poland
Les Hopitaux De Chartres Le Coudray France
Gottsegen National Cardiovascular Center Budapest Hungary
Spitalul Judetean De Urgenta Dr. Constantin Opris Baia Mare Baia Mare Romania
Spaarne Gasthuis Hoofddorp The Netherlands
Diakonessenhuis Stichting Utrecht The Netherlands
Maxima Medisch Centrum Veldhoven The Netherlands
Wojewodzki Szpital Zespolony Im.L.Rydygiera W Toruniu Torun Poland
Мultidisciplinary hospital for active treatment Saint George Pernik OOD Pernik Bulgaria
StudyCor Oy Jyvaskyla Finland
Diakonhjemmet Sykehus AS Oslo Norway
Institutul Inimii De Urgenta Pentru Boli Cardiovasculare Niculae Stancioiu Cluj Napoca Romania
Wojewodzki Szpital Specjalistyczny W Olsztynie Olsztyn Poland
General Hospital Of Nea Ionia Konstantopouleio Patision Nea Ionia Greece
Infer-Med Kft. Pecs Hungary
General Hospital Of Eleusina Thriasio Eleusina Greece
Respublikine Panevezio ligonine VšĮ Panevezys Lithuania
Dolnoslaski Szpital Specjalistyczny Im. T.Marciniaka-Centrum Medycyny Ratunkowej Wroclaw Poland
Universitetska Mnogoprofilna bolnica za aktivno lechenie Deva Maria EOOD Burgas Bulgaria
University Of Szeged Szeged Hungary
Zealand University Hospital, Department of Cardiology Roskilde Denmark
Centre Hospitalier Universitaire De Caen Normandie Caen France
North Estonia Medical Centre Foundation Tallin Estonia
Multispecialty hospital for active treatment Sveta Sofia EOOD Sofia Bulgaria
Budapesti Uzsoki Utcai Korhaz Budapest Hungary
Dijklander Ziekenhuis Hoorn The Netherlands
Semmelweis University Budapest Hungary
Nemocnice Ceske Budejovice a.s. Ceske Budejovice Czechia
Vychodoslovensky Ustav Srdcovych A Cievnych Chorob a.s. Kosice Slovakia
Second Multiprofile Hospital For Active Treatment – Sofia EAD Sofia Bulgaria
Krajska nemocnice Liberec a.s. Liberec Czechia
Hospital Universitario Hm Monteprincipe Boadilla Del Monte Spain
Hospital Universitario Virgen De La Victoria Malaga Spain
Stichting Meander Medisch Centrum Amersfoort The Netherlands
University Of Tartu Tartu Estonia
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie Cracow Poland
Azienda Sanitaria Locale To3 Collegno Italy
Medical Centre Hungarian Defence Forces Budapest Hungary
Azienda Ospedaliera Universitaria Mater Domini Catanzaro Italy
Miedziowe Centrum Zdrowia S.A. Lubin Poland
Polsko-Amerykańskie Kliniki Serca II Oddział Kardiologiczny Bielsko-Biala Poland
Podoleanu G. Cristian-Gheorghe-Calin – Cabinet Medical De Cardiologie Targu Mures Romania
Bjlzozeofd Iskpztfhoocc Bhbha Ivzvnjpuxandb Kopprw Budapest Hungary
Ufif Cfovielr Twpmvc Svk z ozfr Lodz Poland
Zpixqrr Mgwypnp Cnfhrm Sgi z ojcn Lublin Poland
Aaqxtodpe Uyt Amsterdam The Netherlands
Ahvpwilg Uijydeozsq Hvpwznty Lorenskog Norway
Sonndrgdr Raoszej Uswdhxwdyk Mjlgiib Cpsqtr Nijmegen The Netherlands
Seu Exzfcmjcc Hgsugzfs Tpublzy Tilburg The Netherlands
Ckci Dq Newbj Vandoeuvre Les Nancy France
Rhmlej Mtwqomzbahi Herning Denmark
Cmdogqbs Dz Mnsnzowdga Montpellier France
Rsvzfgdbm Zpgvyskdld Sstlwxgcj Arnhem The Netherlands
Kdhmyvpqxrlxa atqzcaxxz Mzbae Jfezzmt Ohbkemjb Prostejov Czechia
Kwiuhperl stfjuj Ostrava Czechia
Snr Kyccsxiv Klxafpsvsnanytukpiaasbox Gqca Karlsbad Germany
Msdtp Tfmsta Ss Ui (etnuzgtchlgjjdwxumqs Berlin Germany
Ezgtzfnzepgqh Bof Baja Hungary
Auytfmrx De Roosbh Zkkeghqdge Bdww Goes The Netherlands
Syyxquib Cimlwk Db Upoiwrm Bzcyiimkq Bucharest Romania
Syhcfplp Cyzktp Mkngrejif dy Ukhqoor Tltuyuloe Timisoara Romania
Svmrcrzj Czujwp dj Ugbookz &svsmbfbuiihbcnbaczaejmyouquh Bucharest Romania
Sfxesjpk Crcstm Jgcfamue Dm Ufgcfmo Bcttwk Brasov Romania
Awqnye Guyikff Hrrersep Evgrd Athens Greece
Gkpznjo Hgtyiixs Ow Pzqzqa Ausie Apoyuvl Patras Greece
Gkyyunm Hmzjbzbv Oc Idflubsj Gq Hpyjqorogw Ioannina Greece
Szvcwgyvecjmesk Pknidljq Lvfkjrsd Pxung Gfoljgpniklb Cmlfblh Krdihmnorzs Pgwvj Ggmsfrcixdmy Bydgoszcz Poland
Kkuhaywvqy Chgpchn Zhwaiwj Sfa z omwa Starogard Gdanski Poland
&mmyyfsrhdpetr cyiubk &etkckg Mvljyyn Ctlokww Bkdoafzsfcwr Efnh Stara Zagora Bulgaria
Ucsxojdkvh Hqrjcahd Lrptnjun Sofia Bulgaria
Wdjwcfaws Sgfdaemw Cmrxtx Os Njjyx Kxhfhgp Svrz Suqo Joensuu Finland
Beoypchzdqitnv Aenvmv Sgavdkbasx Balatonfured Hungary
Pntzjzgc Bratislava Slovakia
Catdsu Hqcvxjitdh Dh Lhbgot Ekxkqf Leiria Portugal
Bugltajrxre Vulheuhqy Oucagdhutbwe Kecskemet Hungary
Lrdqj Glrvfro Hdcbpwkp Om Anniiv Athens Greece
Syyshwyyrrwl Gbcazsy Hlxemqal Athens Greece
Ueedgowghh Hijxiybv Boxtaeaxei Bratislava Slovakia
Saoamwvmj Gzxd Voelklingen Germany
D Slyelqaj Kzzzbfwogp Pfwdaav Pzvcnscy Liepaja Latvia
Kwykvikmbup Vnbxusafz sgpwex Prague Czechia
Ddukprvbki Cwqkzhtosdoe Cpklll (rrgb &tytpkkkoqwc Atydjevxsaw Eyjs Sofia Bulgaria
Iecojggxq Sfdcjf z ohozandkqga oxpdcdjxhfowzsvbfxi Cgatgoo Krfszfcfpxc Iqunqunbbtq Ecffglgtrarzsw i Krosno Poland
Auefjkcnjs Pggqlplx Hbksncbp Dc Mihxuvkgu Marseille France
Uzwxvkq Uxmcaddaby Howjwgji Uppsala Sweden
Hywvslgg Uqdsgkwemz Cgsdmgd Hobkwhsl Helsinki Finland
Rhbyr Adggxdzv kwarisox uiktrmbrtnijg spohqohp Sue Riga Latvia
Anvjnoz Oeevkdxfhrm Uhuokybmfyjvz Cdhwbqnpjsuh Dvrvi Sfrlmk E Dfhqy Szmmeix Dt Tbiwfd Turin Italy
Guemzvtgdfpctrojx Vzehelsgs Pcph Atikzq Erumurwa Ojcukd Ktxkyy Gyor Hungary
Hpcgy Mnebf Oy Rtenjjb Hb Aalesund Norway
Uuvqxbaetgxmhu Cuojqbt Kjcurhqpf Gdansk Poland
Klysi Spx Photjj Gtxh Dortmund Germany
Hksmhqnr Ds Ls Sfzik Ctjh I Scdm Pmd Barcelona Spain
Usxvkryfys Mhznbvl Cmonmp Hcwgplfovlyrucuck Hamburg Germany
Ijpwmkqeh Fop Clriaxxf Afc Eckusjmqswlu Mfzlaype Prague Czechia
Hwfpwefr Uinohyjjfcrty Dx Lr Phplhkyf Madrid Spain
Obqivumixwinqbsekubpvhtdqy Aalst Belgium
Ucowlifliq Hzekfmqut Ptrls Spgcbhjaalz Chfpfvb Fvse Paris France
Fdgcjzbzc Pefr Ln Icbvevscbeqbx Bzzbdnqjt Dkq Hxpiztrv Urizpqlmvgydk Lt Ppi Madrid Spain
Cwqvfpba Hjqnloracppm Ugctzcfwscuxy Dp Vkmr Vigo Spain
Suhxdnvpbfmcgni ukbdf stofktpcu a ctauqtfk cvzgev aenn Banska Bystrica Slovakia
Ksykvyssxdvdjojk hrpkxvnzfcixsap Kokkola Finland
Haqgkonf Uozmrucfgmprr Hmalyfnc Tzgcj y Pwszqq Imcgcjlg Cpjwao dhpbjublehxscgmeo (wods Badalona Spain
Mvwhxjixuspjepxvw Hcswxdtu Frn Agpikm Tepduatrc Ccyasbgrbt Lssj Lovech Bulgaria
Kwicyda zwttpxbvk atep &eywxss Msrnqddxqb nhnyvznjf Úbgb nzc Lujajy ohpn Usti Nad Labem Czechia
Ndjc Seeaemab Jab Zujdfkjc Pvvkcp Plxk Suejk Lodz Poland
Scygvxl Svfi Kluczbork Poland
Cxqjdv Hahuonqqfe E Uustaelzpwepj Dj Comncjh Ewaixn Coimbra Portugal
Wdssjfhonl Spnrzxr Imm Soapnsm Pse W Ptwxdjdre Przemysl Poland
Cwlajelg Hsakmgto Dthpeue Zagreb Croatia
Kolsmgtxwyh a aatvwgduyr sshglp Prague Czechia
Urdnqcwzda Gnmugqp Hhezdoxr Aoxiryt Athens Greece

Want to learn more about this study or check if you can participate? Contact us.

Trial status

Country Status Recruitment Start
Austria Austria
Recruiting
03.11.2021
Belgium Belgium
Recruiting
03.11.2021
Bulgaria Bulgaria
Recruiting
03.11.2021
Croatia Croatia
Not yet recruiting
03.11.2021
Czechia Czechia
Recruiting
03.11.2021
Denmark Denmark
Recruiting
03.11.2021
Estonia Estonia
Recruiting
03.11.2021
Finland Finland
Recruiting
03.11.2021
France France
Recruiting
03.11.2021
Germany Germany
Recruiting
03.11.2021
Greece Greece
Recruiting
03.11.2021
Hungary Hungary
Recruiting
03.11.2021
Italy Italy
Recruiting
03.11.2021
Latvia Latvia
Recruiting
03.11.2021
Lithuania Lithuania
Recruiting
03.11.2021
Norway Norway
Recruiting
03.11.2021
Poland Poland
Recruiting
03.11.2021
Portugal Portugal
Recruiting
03.11.2021
Romania Romania
Recruiting
03.11.2021
Slovakia Slovakia
Recruiting
03.11.2021
Spain Spain
Recruiting
03.11.2021
Sweden Sweden
Recruiting
03.11.2021
The Netherlands The Netherlands
Recruiting
03.11.2021

Trial locations

Investigated drugs:

Selatogrel is a medication being studied for its ability to prevent death and treat heart attacks in people who have recently experienced a heart attack. It is designed to be self-administered by the patient when they notice symptoms that might indicate another heart attack. The goal is to see if this medication can effectively reduce the risk of having another heart attack and improve survival rates.

Investigated diseases:

Acute Myocardial Infarction (AMI) – This condition, commonly known as a heart attack, occurs when blood flow to a part of the heart is blocked for a long enough time that part of the heart muscle is damaged or dies. The blockage is usually caused by a buildup of fat, cholesterol, and other substances, which form a plaque in the coronary arteries. During an AMI, the affected heart muscle loses its blood supply and can become permanently damaged if not treated promptly. Symptoms often include chest pain, shortness of breath, and discomfort in other areas of the upper body. The severity and progression of the condition can vary, with some individuals experiencing mild symptoms and others having more severe complications.

Trial ID:
2023-505438-85-00
Protocol code:
ID-076A301
NCT ID:
NCT04957719
Trial Phase:
Therapeutic confirmatory (Phase III)

Other Trials to Consider

  • Study of ranolazine in patients with ST-elevation heart attack and multiple blocked coronary arteries to improve small blood vessel function

    Recruiting

    2 1 1 1
    Investigated drugs:
    Italy
  • A study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack

    Recruiting

    3 1 1
    Denmark